Genmab
CompanyDeals

FRα ADC Rina-S by Genmab Enters Late-Stage Clinical Trial Following ProfoundBio Acquisition

Dizal Pharmaceutical
CompanyDrug

Dizal Pharmaceutical’s Surufatinib Earns CDE Consideration for Breakthrough Therapy in EGFR exon20ins NSCLC

Hengrui Medicine
CompanyDrug

Hengrui Pharmaceuticals’ HR19042 Capsules Designated as Breakthrough Therapy for Autoimmune Hepatitis by China NMPA

AbbVie
CompanyDrug

NMPA Clears AbbVie’s ABBV-706 for Clinical Trials Targeting SCLC and Neuroendocrine Tumors

Alphamab Oncology
CompanyDeals

Jiangsu Alphamab Biopharmaceuticals Partners with Shanghai Jinmant Biotech for JSKN003 ADC

基石药业
CompanyDrug

CStone Pharmaceuticals’ Partner HengRui Medicine Launches Phase III Trial for CTLA-4 Antibody in HCC

Company

Zephyrm Bioscience Aims for HKEX Main Board with Innovative Cell Therapy Products

CompanyDrug

Akeso Biopharma’s Cadonilimab Secures NMPA Approval for Gastric Cancer Indication